This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed the most recent trading day at $2.25, moving -0.88% from the previous trading session.
Corporate News for Dec 19, 2019
by Zacks Equity Research
Companies In The News Are:
Is REX Shares' Leveraged Cannabis ETN Launch Untimely?
by Sanghamitra Saha
REX Shares has launched two cannabis-related ETNs, one among which is double leveraged. Is the launch untimely?
Options Traders Expect Huge Moves in Aurora (ACB) Stock
by Zacks Equity Research
Investors need to pay close attention to Aurora (ACB) stock based on the movements in the options market lately.
Marijuana ETFs Bounce Back: Can the Rally Last?
by Sanghamitra Saha
Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.
Company News For Nov 21, 2019
by Zacks Equity Research
Companies in the news are: URBN, KNSA, ACB, ENDP
The Zacks Analyst Blog Highlights: Tilray, Canopy Growth and Aurora Cannabis
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tilray, Canopy Growth and Aurora Cannabis
Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?
by Sanghamitra Saha
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
Options Traders Expect Huge Moves in Aurora (ACB) Stock
by Zacks Equity Research
Investors need to pay close attention to Aurora (ACB) stock based on the movements in the options market lately.
Why Marijuana Stocks Plummeted in 2019
by Madeleine Johnson
Marijuana stocks were on a tear last year, but 2019 has sent stock tumbling back down to Earth. What happened?
Aurora Cannabis Inc. (ACB) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of 133.33% and -21.69%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Aurora Cannabis (ACB) in Q1 Earnings?
by Zacks Equity Research
Aurora Cannabis' (ACB) Q1 earnings are likely to reflect cannabis revenue growth and improved gross margin.
5 Trendy Earnings Charts
by Tracey Ryniec
Are cannabis and solar stocks still the place to be for traders in 2019?
What's in Store for Aurora Cannabis' (ACB) Q1 Earnings?
by Zacks Equity Research
Solid prospects in the Canadian and international markets are expected to have driven Aurora Cannabis' (ACB) fiscal first-quarter performance.
What's in Store for Radiant Logistics (RLGT) in Q1 Earnings?
by Zacks Equity Research
While a sluggish freight scenario is likely to affect Radiant Logistics' (RLGT) Q1 results, its higher revenues at the U.S. segment are expected to have aided the top line.
Aurora Cannabis (ACB) Q1 Earnings on Deck: Can Things Turnaround?
by Christopher Vargas
Aurora Cannabis (ACB) is set to report its first quarter results after the closing bell Thursday, November 14th.
U.S.-China Trade Progress, Q3 Earnings Results & Buy Yeti Stock - Free Lunch
by Benjamin Rains
The latest U.S.-China trade war news that could see the world's two largest economies roll back tariffs. Q3 earnings results from the likes of Qualcomm and Square. And why Yeti is a Zacks Rank #1 (Strong Buy) stock...
Aurora Cannabis Inc. (ACB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Buy Cronos (CRON) Stock Ahead of Earnings as Bet on Marijuana Comeback?
by Benjamin Rains
Should investors think about buying some shares of Cronos (CRON) ahead of earnings, as a bet on a marijuana market comeback?
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed at $3.72 in the latest trading session, marking a -1.06% move from the prior day.
4 Highly-Ranked Cheap Stocks Trading Under $10 to Buy Right Now
by Benjamin Rains
Today we highlighted 4 'cheap' stocks that are currently trading for under $10 per share that also sport a Zacks Rank #2 (Buy) or better that investors might want to consider buying right now...
What's in the Offing for Humana's (HUM) Earnings in Q3?
by Zacks Equity Research
Humana's (HUM) third-quarter results are likely to reflect rise in expenses and a negative impact from seasonality on its bottom line.
Genesis Healthcare (GEN) to Post Q3 Earnings: What to Expect
by Zacks Equity Research
Genesis Healthcare's (GEN) third-quarter results are likely to reflect weak revenues, partially offset by same store facility growth and lower expenses.
Aurora Cannabis Inc. (ACB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for DaVita (DVA) This Earnings Season?
by Zacks Equity Research
DaVita (DVA) expects to have gained from calcimimetics in the third quarter.